Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
325.60    -5.00 (-1.51%)
Bid:
325.40
Ask:
325.80
Spread: 0.40 (0.123%)
Market Cap: £1.73b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Interim 2020 Dividend/Enhanced Script Correction

16 Dec 2020 12:00

RNS Number : 8736I
Hammerson PLC
16 December 2020
 

Hammerson plc (the 'Company')

16 December 2020

 

Interim 2020 Dividend and Enhanced Scrip Dividend Alternative - Correction

 

The following amendment has been made to the Interim 2020 Dividend and Enhanced Scrip Dividend Alternative announcement released on 8 December 2020 at 13:15 under RNS No 9480H.

 

Therefore, 225,830,124 New Shares will be admitted to trading on the London Stock Exchange and the Johannesburg Stock Exchange, rather than 189,816,827 New Shares admitted to trading on the London Stock Exchange and 36,013,297 New Shares admitted to trading on the Johannesburg Stock Exchange, as stated in the main body of the announcement.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Hammerson plc

 

Interim 2020 Dividend and Enhanced Scrip Dividend Alternative

 

16 December 2020

 

Further to the announcement of the Interim 2020 Dividend and the Enhanced Scrip Dividend Alternative on 11 November 2020, the Board of Hammerson plc (the Company) announced that valid elections to participate in the Enhanced Scrip Dividend Alternative were received from Shareholders holding 3,108,216,704 Shares. Accordingly, the number of New Shares to be issued under the Enhanced Scrip Dividend Alternative is 225,830,124.

 

Therefore, 225,830,124 New Shares will be admitted to trading on the London Stock Exchange and the Johannesburg Stock Exchange, bringing the total number of issued 5 pence ordinary shares in the Company to 4,057,298,174.

 

The New Shares are expected to be issued and admitted to trading on the Main Market of the London Stock Exchange and the Johannesburg Stock Exchange on 18 December 2020. A further announcement will be released to confirm when those New Shares have been issued and admitted to trading on the respective stock exchange. Unless otherwise stated, capitalised terms in this announcement shall have the meanings given to them in the Circular dated 11 November 2020 in connection with the proposed Interim 2020 Dividend and Enhanced Scrip Dividend Alternative which can be found at: https://www.hammerson.com/investors/shareholderinformation/general-meeting.

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange.

 

Enquiries

Josh Warren, Head of Investor Relations

Tel: +44 20 7887 1053

josh.warren@hammerson.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVKKABBDBDDPBD
Date   Source Headline
29th May 202010:04 amRNSDirector/PDMR Shareholding
27th May 202010:00 amRNSHolding(s) in Company
27th May 20207:00 amRNSCEO succession planning
21st May 202010:00 amRNSHolding(s) in Company
15th May 202010:00 amRNSHolding(s) in Company
14th May 202010:15 amRNSHolding(s) in Company
14th May 20209:30 amRNSHolding(s) in Company
13th May 202010:15 amRNSHolding(s) in Company
12th May 20203:00 pmRNSHolding(s) in Company
12th May 202011:00 amRNSHolding(s) in Company
7th May 202011:30 amRNSHolding(s) in Company
6th May 20207:00 amRNSUpdate on disposal of retail parks portfolio
5th May 20204:00 pmRNSHolding(s) in Company
4th May 20209:30 amRNSHolding(s) in Company
28th Apr 20204:00 pmRNSResult of AGM
28th Apr 20203:00 pmRNSDirector/PDMR Shareholding
27th Apr 202011:00 amRNSArticles of Association
23rd Apr 20201:00 pmRNSUpdate on disposal of retail parks portfolio
21st Apr 20209:15 amRNSHolding(s) in Company
20th Apr 20203:45 pmRNSDirector/PDMR Shareholding
20th Apr 20207:00 amRNSDirector/PDMR Shareholding
7th Apr 20204:30 pmRNSHolding(s) in Company
7th Apr 20202:00 pmRNSHolding(s) in Company
7th Apr 202010:15 amRNSHolding(s) in Company
3rd Apr 20207:00 amRNS2020 Annual General Meeting
30th Mar 20207:00 amRNSCOVID-19 Update
26th Mar 20203:00 pmRNSDirector/PDMR Shareholding
26th Mar 20209:15 amRNSHolding(s) in Company
25th Mar 20201:00 pmRNSDirector/PDMR Shareholding
25th Mar 20208:00 amRNSUpdate on AGM and Remuneration
24th Mar 202010:15 amRNSHolding(s) in Company
23rd Mar 202010:15 amRNSHolding(s) in Company
20th Mar 202010:30 amRNSHolding(s) in Company
19th Mar 20203:00 pmRNSHolding(s) in Company
19th Mar 202010:00 amRNSHolding(s) in Company
19th Mar 20209:30 amRNSHolding(s) in Company
18th Mar 202011:00 amRNSHolding(s) in Company
17th Mar 202011:00 amRNSAnnual Report and Notice of AGM
17th Mar 202010:30 amRNSHolding(s) in Company
13th Mar 202012:00 pmRNSDirector/PDMR Shareholding
12th Mar 202010:30 amRNSHolding(s) in Company
12th Mar 20207:00 amRNSAppointment of General Counsel & Company Secretary
11th Mar 20203:50 pmRNSDirector/PDMR Shareholding
10th Mar 20202:30 pmRNSDirector/PDMR Shareholding
10th Mar 202011:00 amRNSDirector/PDMR Shareholding
9th Mar 202010:30 amRNSDirector/PDMR Shareholding
5th Mar 20203:00 pmRNSDirector/PDMR Shareholding
5th Mar 202011:30 amRNSHolding(s) in Company
4th Mar 202010:00 amRNSDividend Currency Conversion Announcement
3rd Mar 20203:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.